.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AA10_GestodeneAndEthinylestra.GestodeneAndEthinylestra .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03A_HormonalContraceptivesForSystemicUse.G03AA10_GestodeneAndEthinylestra.GestodeneAndEthinylestra| name: | GestodeneAndEthinylestradiol |
| ATC code: | G03AA10 | route: | oral |
| n-compartments | 2 |
Gestodene and ethinylestradiol is a combined oral contraceptive preparation containing the progestin gestodene and the estrogen ethinylestradiol. It is used for female contraception to prevent pregnancy. The combination is approved and widely used today for birth control.
Pharmacokinetic parameters reported for healthy adult women after administration of 0.075 mg gestodene and 0.03 mg ethinylestradiol orally, single dose, under fasting conditions.
Kuhnz, W (1990). Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women. American journal of obstetrics and gynecology 163(6 Pt 2) 2120–2127. DOI:10.1016/0002-9378(90)90551-h PUBMED:https://pubmed.ncbi.nlm.nih.gov/2124087
Bergink, W, et al., & Qvist, I (1990). Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. American journal of obstetrics and gynecology 163(6 Pt 2) 2132–2137. DOI:10.1016/0002-9378(90)90553-j PUBMED:https://pubmed.ncbi.nlm.nih.gov/2147817